F-star Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2020 to Q3 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
F-star Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2022.
  • F-star Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2022 was -174 %, a 84.9% increase year-over-year.
  • F-star Therapeutics, Inc. annual Operating Margin for 2021 was -145 %, a 27% increase from 2020.
  • F-star Therapeutics, Inc. annual Operating Margin for 2020 was -199 %, a 150% decline from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -174 +975 +84.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -157 +151 +49% Apr 1, 2022 Jun 30, 2022
Q1 2022 -150 +66.6 +30.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -145 +53.8 +27% Oct 1, 2021 Dec 31, 2021
Q3 2021 -1.15K Jul 1, 2021 Sep 30, 2021
Q2 2021 -308 Apr 1, 2021 Jun 30, 2021
Q1 2021 -217 Jan 1, 2021 Mar 31, 2021
Q4 2020 -199 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.